谷歌浏览器插件
订阅小程序
在清言上使用

Comparison of Multiple Sclerosis Disease Activity (MSDA) Test Results Between Patients Treated with Ublituximab and Teriflunomide in the Phase 3 ULTIMATE I and II Studies

Ferhan Qureshi,Shannon McCurdy, Elisa Sheng,Wayne Hu,Ati Ghoreyshi, Alexander Hari, Srushti Tiwari, Christopher A. Garner,Hari Miskin,John Foley

MULTIPLE SCLEROSIS JOURNAL(2024)

引用 0|浏览1
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要